QUEST DIAGNOSTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.1 USD | +1.00% |
|
+8.42% | -0.15% |
| 04:19pm | Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155 | MT |
| 03:49pm | UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating | MT |
Business Summary
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Number of employees: 50,000
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Diagnostic Information Services
97.0
%
| 9,609 | 97.2 % | 8,976 | 97.0 % | -6.59% |
All Other
3.0
%
| 274 | 2.8 % | 276 | 3.0 % | +0.73% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 9,883 | 100.0 % | 9,252 | 100.0 % | -6.38% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 22-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | 19-02-17 | |
Shawn Bevec
IRC | Investor Relations Contact | - | - |
Sean Mersten
SEC | Corporate Secretary | - | - |
Mark Delaney
PRN | Corporate Officer/Principal | - | 22-02-28 |
Michael Deppe
AUD | Comptroller/Controller/Auditor | 59 | 97-12-31 |
Alyssa Waxenberg
PRN | Corporate Officer/Principal | 53 | 20-12-31 |
Doug Lang
PRN | Corporate Officer/Principal | - | 13-03-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 19-02-17 |
Timothy Ring
BRD | Director/Board Member | 66 | 11-12-06 |
Gail Wilensky
BRD | Director/Board Member | 80 | 96-12-31 |
Gary M. Pfeiffer
BRD | Director/Board Member | 74 | 04-11-30 |
Timothy Main
BRD | Director/Board Member | 66 | 14-01-12 |
Vicky Gregg
BRD | Director/Board Member | 69 | 14-07-21 |
Tracey Doi
BRD | Director/Board Member | 63 | 21-08-16 |
Wright Lassiter
BRD | Director/Board Member | 60 | 20-03-11 |
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Luis A. Diaz
BRD | Director/Board Member | 53 | 23-05-16 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 162,000,000 | 110,582,365 ( 68.26 %) | 51,000,000 ( 31.48 %) | 68.26 % |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. |
Biotechnology
|
Quest Diagnostics India Pvt Ltd.
 Quest Diagnostics India Pvt Ltd. Medical/Nursing ServicesHealth Services Quest Diagnostics India Pvt Ltd. provides pathology and clinical laboratory testing services. It offers employee life cycle approach, pre-employment screening, drug testing solutions, occupational exposure screening and monitoring blueprint for wellness driving healthy behavior & outcomes. The company is headquartered in Gurgaon, India. |
Medical/Nursing Services
|
Quest Diagnostics HTAS India Pvt Ltd.
|
Sector
Sales per Business
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.35% | 15.18B | |
| -14.05% | 86.34B | |
| +17.45% | 84.49B | |
| +11.97% | 29.68B | |
| -9.49% | 17.5B | |
| -2.57% | 16.67B | |
| -3.70% | 12.71B | |
| +2.87% | 12.53B | |
| -30.53% | 11.89B | |
| +27.18% | 11.74B |
- Stock Market
- Equities
- DGX Stock
- Company Quest Diagnostics Incorporated
